Will First Niagara Financial Group Inc. (FNFG) and Biocept Inc(BIOC) Justify The Risk And Bring The Returns?
New York, NY – GDP INSIDER – 03/18/2015.
This article discusses two companies: First Niagara Financial Group Inc. (NASDAQ:FNFG) and Biocept Inc(NASDAQ:BIOC)
First Niagara Financial Group Inc. (NASDAQ:FNFG) started to reverse recent losses with the stock closing up 0.33% or $0.03 to close at $9.14, on light trading volume of 2.20 million compared to its 30-day average trading volume of 3.20 million. The $3.22 billion market cap company, which oscillated between $9.05 and $9.14 during yesterday’s trading, currently trading 33.28% above its one year low of $6.86 and only 1.14% below its one year high of $9.25. The company has performed well over the past three months. The stock is up 9.59% compared to the S&P 500 index that is up 3.05% over the same period.
First Niagara Financial Group Inc is currently sitting 8.54% above its 50-day moving average of $8.44 and 10.30% above its 200-day moving average of $8.29. While the MFI of 64.83 is not concerning, the RSI of 69.66 is on the verge of pushing into more concerning territory. That said, the stock could move higher, and these technical are not yet indicating that a correction is on the horizon. With negative EPS of -2.12 and quarterly revenue growth of -2.60%, the stock may be better to hold than buy at this time.
Biocept Inc (NASDAQ:BIOC) lost fifteen cents to end yesterday’s trading session at $2.39, a 5.19% decline in value from its previous closing price of $2.39 on lower than normal trading volume of 1.94 million compared to its three month average trading volume of 3.16 million. Despite the loss, the California-based commercial-stage cancer diagnostics company remains well above its one year low of $1.09 set on February 10, 2015. Biocept Inc’s decline in value came despite the fact that the company did not make any significant announcements or release any financial figures. In fact, since releasing its financial figures on March 09, 2015, the company’s stock had fallen 29.29% so far.
The RSI of 44.59 indicates the stock is not overvalued at the current levels, the MFI of 44.58 shows that money is flowing in the right direction and still has room to improve. Biocept Inc is showing good quarterly revenue (yoy) of 302.20% and return on investment (ttm) of 156.90% making it a potential investment if you buy at the right time.
UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.
UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Disclosure: UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.